|
I became interested in investing in biotech in the late 80s while I was a
Ph.D. candidate in the Biochemistry Department at the University of
California, Riverside, in an adjunct molecular endocrinology laboratory of
UCLA School of Medicine. After I finished the doctoral degree, I moved to
New York in 1993 and worked at the prestigious Rockefeller University. I
was a founder and publisher of Bio/Medical Technology Stock newsletter in
1993. The letter was later acquired in 1996 when I became a
biopharmaceutical investment banker/venture capitalist. During 1993-1996,
I read as many books as I could find on investing and valuation. I became
interested in value investing by Graham and Buffett. Later, I was able to
take finance classes in the part-time MBA program at New York University
and finally obtained an MBA in finance. In 1997, suggested by Michael
Penn, I decided to write a handbook on investing in biotech. Since then,
through Mr. Market's many ups and downs, and my working at different
capacities on Wall Street, I finally finished the assignment in late 2001.
I believe this investment guide is unique in that it aims to have both
breadth and depth. I also endeavored to discuss biotech investing from asset
management and risk management point of, in the hope that it will be useful
for biotech experts, bioentrepreneurs, and individual biotech investors alike.
A guide to investing in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. |
|
